These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7709858)

  • 1. Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei.
    Pospichal H; Brun R; Kaminsky R; Jenni L
    Acta Trop; 1994 Dec; 58(3-4):187-97. PubMed ID: 7709858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Kaminsky R
    Trop Med Parasitol; 1990 Jun; 41(2):208-12. PubMed ID: 2382101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of in vitro cultivation on the stability of resistance of Trypanosoma brucei brucei to diminazene, isometamidium, quinapyramine, and Mel B.
    Kaminsky R; Zweygarth E
    J Parasitol; 1989 Feb; 75(1):42-5. PubMed ID: 2918443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism.
    Fairlamb AH; Carter NS; Cunningham M; Smith K
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):213-22. PubMed ID: 1501641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei.
    Dukes P
    Trans R Soc Trop Med Hyg; 1984; 78(6):711-25. PubMed ID: 6241967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diamidine diminazene aceturate is a substrate for the high-affinity pentamidine transporter: implications for the development of high resistance levels in trypanosomes.
    Teka IA; Kazibwe AJ; El-Sabbagh N; Al-Salabi MI; Ward CP; Eze AA; Munday JC; Mäser P; Matovu E; Barrett MP; de Koning HP
    Mol Pharmacol; 2011 Jul; 80(1):110-6. PubMed ID: 21436312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin.
    Scott AG; Tait A; Turner CM
    Acta Trop; 1996 Feb; 60(4):251-62. PubMed ID: 8659324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats.
    Anene BM; Ezeokonkwo RC; Mmesirionye TI; Tettey JN; Brock JM; Barrett MP; De Koning HP
    Parasitology; 2006 Jan; 132(Pt 1):127-33. PubMed ID: 16393361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.
    Barrett MP; Fairlamb AH
    Parasitol Today; 1999 Apr; 15(4):136-40. PubMed ID: 10322334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test.
    Stewart ML; Krishna S; Burchmore RJ; Brun R; de Koning HP; Boykin DW; Tidwell RR; Hall JE; Barrett MP
    Lancet; 2005 Aug 6-12; 366(9484):486-7. PubMed ID: 16084257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
    Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP
    Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of trypanocidal drugs on the transmission of Trypanosoma brucei brucei by Glossina morsitans centralis.
    Jefferies D; Jenni L
    Acta Trop; 1987 Mar; 44(1):23-8. PubMed ID: 2884836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of experimental trypanocidal compounds against a multiple drug-resistant Trypanosoma brucei brucei stock in mice.
    Zweygarth E; Röttcher D
    Parasitol Res; 1989; 75(3):178-82. PubMed ID: 2710771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
    Suswam EA; Taylor DW; Ross CA; Martin RJ
    Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model.
    Ndung'u K; Murilla GA; Thuita JK; Ngae GN; Auma JE; Gitonga PK; Thungu DK; Kurgat RK; Chemuliti JK; Mdachi RE
    PLoS One; 2020; 15(11):e0229060. PubMed ID: 33151938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma brucei evansi: dyskinetoplasia and loss of infectivity after long-term in vitro cultivation.
    Zweygarth E; Kaminsky R; Webster P
    Acta Trop; 1990 Dec; 48(2):95-9. PubMed ID: 1980574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story.
    Baker N; de Koning HP; Mäser P; Horn D
    Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.